Organigram (OGI) Scheduled to Post Earnings on Tuesday

Organigram (TSE:OGIGet Free Report) is set to release its earnings data before the market opens on Tuesday, August 13th. Analysts expect Organigram to post earnings of C($0.07) per share for the quarter.

Organigram (TSE:OGIGet Free Report) last posted its quarterly earnings results on Tuesday, May 14th. The company reported C($0.16) earnings per share for the quarter, missing the consensus estimate of C($0.08) by C($0.08). The company had revenue of C$37.63 million during the quarter, compared to analysts’ expectations of C$38.20 million. Organigram had a negative return on equity of 54.53% and a negative net margin of 153.80%.

Organigram Stock Performance

Organigram stock opened at C$2.10 on Wednesday. The company has a quick ratio of 2.62, a current ratio of 6.95 and a debt-to-equity ratio of 1.55. The company has a market capitalization of C$216.30 million, a P/E ratio of -0.84, a PEG ratio of 0.42 and a beta of 1.13. The stock’s 50 day moving average is C$2.21 and its 200 day moving average is C$2.53. Organigram has a twelve month low of C$1.35 and a twelve month high of C$3.95.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on OGI. Canaccord Genuity Group cut their price target on Organigram from C$3.75 to C$3.25 and set a “speculative buy” rating on the stock in a research note on Wednesday, May 15th. Jefferies Financial Group cut their target price on Organigram from C$4.40 to C$4.35 in a research note on Friday, May 17th.

Check Out Our Latest Stock Report on Organigram

Insider Buying and Selling

In related news, Senior Officer Paolo De Luca sold 11,899 shares of the firm’s stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of C$2.61, for a total value of C$31,056.39. 27.16% of the stock is owned by insiders.

About Organigram

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Featured Articles

Earnings History for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.